Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, California, USA.
Saint Louis University, Saint Louis, Missouri, USA.
J Virol. 2020 May 4;94(10). doi: 10.1128/JVI.00089-20.
Members of the flavivirus genus share a high level of sequence similarity and often circulate in the same geographical regions. However, whether T cells induced by one viral species cross-react with other related flaviviruses has not been globally addressed. In this study, we tested pools of epitopes derived from dengue (DENV), Zika (ZIKV), Japanese encephalitis (JEV), West Nile (WNV), and yellow fever (YFV) viruses by intracellular cytokine staining (ICS) using peripheral blood mononuclear cells (PBMCs) of individuals naturally exposed to DENV or immunized with DENV (TV005) or YF17D vaccine. CD8 T cell responses recognized epitopes from multiple flaviviruses; however, the magnitude of cross-reactive responses was consistently severalfold lower than those to the autologous epitope pools and was associated with lower expression of activation markers such as CD40L, CD69, and CD137. Next, we characterized the antigen sensitivity of short-term T cell lines (TCL) representing 29 different individual epitope/donor combinations. TCL derived from DENV monovalent vaccinees induced CD8 and CD4 T cells that cross-reacted within the DENV serocomplex but were consistently associated with >100-fold-lower antigen sensitivity for most other flaviviruses, with no cross-recognition of YFV-derived peptides. CD8 and CD4 TCL from YF17D vaccinees were associated with very limited cross-reactivity with any other flaviviruses and in five out of eight cases >1,000-fold-lower antigen sensitivity. Overall, our data suggest limited cross-reactivity for both CD4 and CD8 T cell responses between flaviviruses and have implications for understanding immunity elicited by natural infection and strategies to develop live attenuated vaccines against flaviviral species. The envelope (E) protein is the dominant target of neutralizing antibodies for dengue virus (DENV) and yellow fever virus (YFV). Accordingly, several DENV vaccine constructs use the E protein in a live attenuated vaccine format, utilizing a backbone derived from a heterologous flavivirus (such as YF) as a delivery vector. This backbone comprises the nonstructural (NS) and capsid (C) antigens, which are dominant targets of T cell responses. Here, we demonstrate that cross-reactivity at the level of T cell responses among different flaviviruses is very limited, despite high levels of sequence homology. Thus, the use of heterologous flavivirus species as a live attenuated vaccine vector is not likely to generate optimal T cell responses and might thus impair vaccine performance.
黄病毒属的成员具有高度的序列相似性,通常在同一地理区域内传播。然而,一种病毒诱导的 T 细胞是否与其他相关的黄病毒发生交叉反应尚未得到全球关注。在这项研究中,我们通过使用来自自然感染登革热(DENV)或接种 DENV(TV005)或黄热病 17D 疫苗的个体外周血单核细胞(PBMC)进行细胞内细胞因子染色(ICS),测试了来自登革热、寨卡、日本脑炎、西尼罗河和黄热病病毒的表位池。CD8 T 细胞反应识别来自多种黄病毒的表位;然而,交叉反应性反应的幅度始终比自身表位池低几个数量级,并且与较低的活化标志物如 CD40L、CD69 和 CD137 的表达相关。接下来,我们使用代表 29 种不同个体表位/供体组合的短期 T 细胞系(TCL)来表征抗原敏感性。来自 DENV 单价疫苗接种者的 TCL 诱导了 CD8 和 CD4 T 细胞,这些细胞在 DENV 血清型内发生交叉反应,但与大多数其他黄病毒的抗原敏感性始终低 100 倍以上,对黄热病衍生肽没有交叉识别。来自黄热病 17D 疫苗接种者的 CD8 和 CD4 TCL 与其他任何黄病毒的交叉反应性非常有限,在八种情况下有五种抗原敏感性低 1000 倍以上。总体而言,我们的数据表明 CD4 和 CD8 T 细胞反应之间对黄病毒的交叉反应性有限,这对理解自然感染引起的免疫和开发针对黄病毒的活减毒疫苗的策略具有重要意义。包膜(E)蛋白是登革热病毒(DENV)和黄热病病毒(YFV)中和抗体的主要靶标。因此,几种 DENV 疫苗构建体使用 E 蛋白作为活减毒疫苗的形式,利用来自异源黄病毒(如 YF)的骨架作为递送载体。该骨架包含非结构(NS)和衣壳(C)抗原,这些抗原是 T 细胞反应的主要靶标。在这里,我们证明尽管存在高度的序列同源性,但不同黄病毒之间的 T 细胞反应的交叉反应性非常有限。因此,使用异源黄病毒作为活减毒疫苗载体不太可能产生最佳的 T 细胞反应,因此可能会损害疫苗的性能。